The Hereditary Breast and Ovarian Cancer Panel is a genetic test designed to identify inherited mutations associated with increased risk of breast, ovarian, and related cancers. It commonly analyzes genes such as BRCA1, BRCA2, and other clinically significant cancer-related genes. The purpose of this test is to help assess hereditary cancer risk, support early detection and preventive care, guide personalized treatment decisions, and provide important risk information for family members.
No, the test identifies inherited genetic risk factors but does not diagnose all breast or ovarian cancer cases directly.
Testing may be considered in adulthood or earlier when strong family history or hereditary cancer risk factors are present.
Certainly, men can carry hereditary cancer mutations and may face increased risks for prostate, pancreatic, breast, and other cancers.
A positive result identifies an inherited mutation associated with increased cancer risk and may require enhanced surveillance or preventive care.
A negative result means no significant inherited mutation was detected, although personal and family history may still affect cancer risk.
BRCA1 and BRCA2 genes help repair damaged DNA. Harmful mutations can increase the risk of breast, ovarian, pancreatic, and prostate cancers.
Yes, healthy individuals with strong family history or inherited cancer concerns may undergo testing to evaluate future cancer risk.
...
Didn't recieved OTP Yet? Resend OTP